Navigating the realm of terminal care and access to medications like Pentobarbital in New South Wales, the state, requires a careful understanding of the complex legal framework. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (this program) and is therefore not commonly prescribed by clinical profess